KlaffL, CaoD, DellvaMA, et al.Ultra rapid Lispro improves postprandial glucose control compared with Lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study. Diabetes Obes Metab, 2020; 22:1799–1807; doi: 10.1111/dom.14100.
2.
WarrenM, BodeB, ChoJI, et al.Improved postprandial glucose control with ultra rapid Lispro versus Lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2. Diabetes Obes Metab, 2021; 23:1552–1561; doi: 10.1111/dom.14368.
3.
BodeB, CarlsonA, LiuR, et al.Ultrarapid Lispro demonstrates similar time in target range to Lispro with a hybrid closed-loop system. Diabetes Technol Ther, 2021; 23:828–836; doi: 10.1089/dia.2021.0184.
4.
DovcK, PionaC, Yeşiltepe MutluG, et al.Faster compared with standard insulin aspart during day-and-night fully closed-loop insulin therapy in type 1 diabetes: A double-blind randomized crossover trial. Diabetes Care, 2020; 43:29–36; doi: 10.2337/dc19-0895.
5.
BoughtonCK, HartnellS, ThabitH, et al.Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study. Diabetes Obes Metab, 2021; 23:1389–1396; doi: 10.1111/dom.14355.
